{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:36:37Z","timestamp":1760852197901},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1007\/bf02246077","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T05:36:56Z","timestamp":1132033016000},"page":"373-378","source":"Crossref","is-referenced-by-count":38,"title":["Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxinN-methyl-4-phenylpyridinium (MMP+) towards cultured dopaminergic neuroblastoma cells"],"prefix":"10.1007","volume":"121","author":[{"given":"J.","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02246077_CR1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0091-3057(93)90571-A","volume":"46","author":"SY Ablordeppey","year":"1993","unstructured":"Ablordeppey SY, Borne RF (1993) Detection of a neurotoxic quaternary pyridinium metabolites in the liver of haloperidol-treated rats. Pharmacol Biochem Behav 46:739\u2013744","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246077_CR2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(89)91017-2","volume":"493","author":"CR Ashby Jr","year":"1989","unstructured":"Ashby CR Jr, Hitzemann R, Rubinstein JE, Wang RY (1989) One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat. Brain Res 493:194\u2013197","journal-title":"Brain Res"},{"key":"BF02246077_CR3","first-page":"385","volume-title":"Goodman and Gilman's pharmacological basis of therapeutics","author":"RJ Baldessarini","year":"1985","unstructured":"Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Gilman GA, Goodman LS, Rall TW, Murad F (eds) Goodman and Gilman's pharmacological basis of therapeutics, 7th edn. Macmillan, New York, pp 385\u2013445","edition":"7th edn."},{"key":"BF02246077_CR4","first-page":"822","volume":"270","author":"J Bloomquist","year":"1994","unstructured":"Bloomquist J, King E, Wright A, Mytilineou C, Kimura K, Catagnoli K, Castagoli N Jr (1994) 1-Methyl-4-phenylpyridinium-like neurotoxicity of pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies. J Pharmacol Exp Ther 270:822\u2013830","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246077_CR5","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/0006-291X(91)92101-O","volume":"181","author":"B DiPasquale","year":"1991","unstructured":"DiPasquale B, Marini AM, Youle RJ (1991) Apoptosis and DNA degradation induced byN-methyl-4-phenylpyridinium in neurons. Biochem Biophy Res Commun 181:1442\u20131448","journal-title":"Biochem Biophy Res Commun"},{"key":"BF02246077_CR6","first-page":"755","volume":"67","author":"R Dom","year":"1967","unstructured":"Dom R (1967) Local glial reaction in the CNS of albino-rats in response to the administration of a neuroleptic drug (butyrophenone). Acta Neurol Belg. 67:755\u2013762","journal-title":"Acta Neurol Belg"},{"key":"BF02246077_CR7","volume-title":"The metabolism of haloperidol","author":"J Fang","year":"1992","unstructured":"Fang J (1992) The metabolism of haloperidol. PhD thesis, King's College, University of London, London, UK"},{"key":"BF02246077_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-4274(91)90062-B","volume":"59","author":"J Fang","year":"1991","unstructured":"Fang J, Gorrod JW (1991) Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite. Toxicol Lett 59:117\u2013123","journal-title":"Toxicol Lett"},{"key":"BF02246077_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0378-4347(93)80318-X","volume":"614","author":"J Fang","year":"1993","unstructured":"Fang J, Gorrod JW (1993) High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations. J Chromatogr 614:267\u2013273","journal-title":"J Chromatogr"},{"key":"BF02246077_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-1176(92)87012-4","volume":"122","author":"J Fang","year":"1992","unstructured":"Fang J, Gorrod JW, Kajbaf M, Lamb J, Naylor S (1992) Investigation of the neuroleptic drug haloperidol and its metabolites using tandem mass spectrometry. Int J Mass Spectrom Ion Proc 122:121\u2013131","journal-title":"Int J Mass Spectrom Ion Proc"},{"key":"BF02246077_CR11","first-page":"157","volume-title":"Drug metabolism in man","author":"JW Gorrod","year":"1978","unstructured":"Gorrod JW (1978) Extra-hepatic metabolism of drugs. In Gorrod JW, Beckett AH (eds) Drug metabolism in man. Taylor and Francis, London, pp. 157\u2013174"},{"key":"BF02246077_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/00498259309059390","volume":"23","author":"JW Gorrod","year":"1993","unstructured":"Gorrod JW, Fang J (1993) On the metabolism of haloperidol. Xenobiotica 23:495\u2013508","journal-title":"Xenobiotica"},{"issue":"suppl.","key":"BF02246077_CR13","first-page":"71","volume":"29","author":"R Grohmann","year":"1990","unstructured":"Grohmann R, Koch R, Schmidt LG (1990) Extrapyramidal symptoms in neuroleptic recipients. Agent Actions (suppl.) 29:71\u201382","journal-title":"Agent Actions"},{"key":"BF02246077_CR14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-4347(92)80392-4","volume":"579","author":"K Igarashi","year":"1992","unstructured":"Igarashi K, Castagnoli N Jr (1992) Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr 579:277\u2013283","journal-title":"J Chromatogr"},{"key":"BF02246077_CR15","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin,N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metaboliteN-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173\u20132177","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02246077_CR16","first-page":"1198","volume":"253","author":"LH Jiang","year":"1990","unstructured":"Jiang LH, Kasser RJ, Altar CA, Wang RY (1990) One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists. J Pharmacol Exp Ther 253:1198\u20131205","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246077_CR17","first-page":"51","volume":"27","author":"J Koizumi","year":"1973","unstructured":"Koizumi J, Shiraishi H (1973) Synaptic changes in the rabbit pallidum following long-term haloperidol administration. Folia Psychiatr Neurol Jpn 27:51\u201357","journal-title":"Folia Psychiatr Neurol Jpn"},{"key":"BF02246077_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.ne.11.030188.000501","volume":"11","author":"IJ Kopin","year":"1988","unstructured":"Kopin IJ, Markey SP (1988) MPTP toxicity: implications for research in Parkinson's disease. Ann Rev Neurosci 11:81\u201396","journal-title":"Ann Rev Neurosci"},{"key":"BF02246077_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01250639","volume":"75","author":"J Kornhubner","year":"1989","unstructured":"Kornhubner J, Riederer P, Reynolds GP, Beckmann H, Jellinger K, Gabriel E (1989)3H-Spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm 75:1\u201310","journal-title":"J Neural Transm"},{"key":"BF02246077_CR20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(89)90867-6","volume":"489","author":"CK Meshul","year":"1989","unstructured":"Meshul CK, Casey DE (1989) Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res 489:338\u2013346","journal-title":"Brain Res"},{"key":"BF02246077_CR21","first-page":"95","volume":"13","author":"M Mesnil","year":"1984","unstructured":"Mesnil M, Testa B, Jenner P (1984) Xenobiotic metabolism by brain monooxygenases and other cerebral enzymes. Adv Drug Res 13:95\u2013207","journal-title":"Adv Drug Res"},{"key":"BF02246077_CR22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"BF02246077_CR23","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ, Vyas I, Heillila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36:2503\u20132508","journal-title":"Life Sci"},{"key":"BF02246077_CR24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000112702","volume":"5","author":"JR Perez-Polo","year":"1982","unstructured":"Perez-Polo JR, Triffany-Catiglioni E, Ziegler MG, Werrbach K (1982) Effect of nerve growth factor on catecholamine metabolism in human neuroblastoma clone (SH-SY5Y). Dev Neurosci 5:418\u2013423","journal-title":"Dev Neurosci"},{"key":"BF02246077_CR25","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1523\/JNEUROSCI.13-10-04246.1993","volume":"13","author":"C Pifl","year":"1993","unstructured":"Pifl C, Giros B, Caron MG (1993) Dopamine transporter expression confers cytotoxicity to low doses of the Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J Neurosci 13:4246\u20134253","journal-title":"J Neurosci"},{"key":"BF02246077_CR26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0024-3205(86)90037-8","volume":"39","author":"RR Ramsay","year":"1986","unstructured":"Ramsay RR, Dadgar J, Trevor A, Singer TP (1986) Energy-driven uptake ofN-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. Life Sci 39:581\u2013588","journal-title":"Life Sci"},{"key":"BF02246077_CR27","first-page":"367","volume-title":"Mechanism of drug action","author":"H Rollema","year":"1991","unstructured":"Rollema H, Subramanyam B, Skolnik M, d'Engelbronner J, Castagnoli N Jr (1991) MPP+-like neurotoxicity of HPP+, a pyridinium metabolite of haloperidol: a microdialysis study. In: Rollema H, Westerink BHC, Drjfhout WJ (eds) Mechanism of drug action. University Groningen Press, Groningen, Netherlands, pp 367\u2013369"},{"key":"BF02246077_CR28","first-page":"741","volume":"71","author":"RA Ross","year":"1983","unstructured":"Ross RA, Spengler BA, Biedler JL (1983) Coordinate and morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71:741\u2013747","journal-title":"J Natl Cancer Inst"},{"key":"BF02246077_CR29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF02244615","volume":"100","author":"RE See","year":"1990","unstructured":"See RE, Ellison G (1990) Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rat. Psychopharmacology 100:404\u2013412","journal-title":"Psychopharmacology"},{"key":"BF02246077_CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","volume":"1","author":"P Seeman","year":"1987","unstructured":"Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:133\u2013152","journal-title":"Synapse"},{"issue":"suppl. 4","key":"BF02246077_CR31","first-page":"35","volume":"8","author":"P Seeman","year":"1988","unstructured":"Seeman P (1988) Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes. J Clin Psychopharmacol 8 [suppl. 4]:35\u201395","journal-title":"J Clin Psychopharmacol"},{"key":"BF02246077_CR32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.1992.tb08880.x","volume":"59","author":"MB Spina","year":"1992","unstructured":"Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine andN-methyl-4-pheynylpyridinum ion toxicity: involvement of the glutathione system. J Neurochem 59:99\u2013106","journal-title":"J Neurochem"},{"key":"BF02246077_CR33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0006-291X(90)91936-M","volume":"166","author":"B Subramanyam","year":"1990","unstructured":"Subramanyam B, Rollema H, Woolf T, Castagnoli N Jr (1990) Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats. Biochem Biophys Res Commun 166:238\u2013244","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02246077_CR34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/tx00019a017","volume":"4","author":"B Subramanyam","year":"1991","unstructured":"Subramanyam B, Woolf T, Castagnoli N Jr (1991) Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite. Chem Res Toxicol 4:123\u2013128","journal-title":"Chem Res Toxicol"},{"key":"BF02246077_CR35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","volume":"101","author":"JL Weddington","year":"1990","unstructured":"Weddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431\u2013447","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02246077\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:33:34Z","timestamp":1557941614000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02246077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["BF02246077"],"URL":"https:\/\/doi.org\/10.1007\/bf02246077","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]}}}